1.
Establishment of a model of Irinotecan- induced Diarrhea in Nude Mice Bearing Human Small-cell Lung Cancer
依立替康致小细胞肺癌荷瘤鼠腹泻模型的建立
2.
Clinical Efficacy of Irinotecan for Extensive Small-Cell Lung Cancer
依立替康应用于广泛期小细胞肺癌的疗效观察
3.
The Study of the Intervention of Banxiaxiexin Decoction against Irinotecan- induced Diarrhea in Nude Mice Bearing Human Small-cell Lung Cancer
半夏泻心汤干预依立替康致小细胞肺癌荷瘤鼠腹泻的研究
4.
Clinical study on combination chemotherapy with irinotecan,fluorouracil,and leucovorin in patients with advanced gastric carcinoma
依立替康/氟尿嘧啶/亚叶酸三药联用治疗晚期胃癌的临床疗效观察
5.
Study on the Improvement and Mechanism of Banxiaxiexin Decoction against Irinotecan-induced Diarrhea in Nude Mice Bearing the Tumor of Human Small-cell Lung Cancer
半夏泻心汤对依立替康致小细胞肺癌荷瘤鼠腹泻的改善作用及机理研究
6.
Irinotecan/cisplatin versus Etoposide/cisplatin for Patients with Extensive Stage Small Cell Lung Cancer:A Systematic Review
依立替康联合顺铂与足叶乙甙联合顺铂治疗广泛期小细胞肺癌的系统评价
7.
Efficacies of capecitabine combined with irinotecan or rh-endostatin for treatment of oxaliplatin-resistant patients with advanced colorectal cancer
卡培他滨联合血管内皮抑素或依立替康治疗奥沙利铂耐药晚期结直肠癌
8.
Irinotecan in the Treament of Small Cell Lung Cancer (SCLC): A Systematic Review
伊立替康治疗小细胞肺癌的系统评价
9.
Effect of Irinotecan Combined with Radiotherapy in Patients with Advanced Non-small Cell Lung Cancer
伊立替康联合放疗治疗晚期NSCLC的疗效
10.
Clinical comparison between single agent of irinotecan and combination of irinotecan and cispaltin in second-line treatment of small cell lung cancer
伊立替康单药与伊立替康联合顺铂二线治疗小细胞肺癌的临床比较
11.
Preparation of Irinotecan Hydrochloride Liposome and the in Vitro and in Vivo Pharmaceutical Behaviors of Irinotecan Liposome;
伊立替康脂质体的制备及体内外行为研究
12.
Determination of Stabilization of Irinotecan in 0.9% Sodium Chloride Injection by HPLC
伊立替康浓度测定及其输液稳定性考察
13.
Clinical Study of Advanced Ovarial Cancer with Irinotecan and Cisplatin Regimen Combination
伊立替康联合顺铂治疗晚期卵巢癌的疗效观察
14.
The Efficacy Observation of Irinotecan Therapy of Patients with Recurrent Advanced Ovarian Carcinoma
伊立替康治疗复发性晚期卵巢癌的临床观察
15.
CLINICAL OBSERVATION ON THE IRINOTECAN PLUS CISPLATIN FOR ADVANCED ESOPHAGEAL CANCER
伊立替康联合顺铂治疗晚期食管癌疗效观察
16.
Irinotecan combined with capecitabine in line-2 treatment of locally advanced or metastatic gastric cancer
伊立替康联合卡培他滨二线治疗晚期胃癌
17.
Technetium[99mTc] Etifenin
锝[99mTc]依替菲宁
18.
Abuse of Dependence-Producing Substances and Rehabilitation Centers Act, No. 41 of 1971
滥用产生依赖性物质和设立康复中心法，